From improving metabolism and enhancing performance to calming inflammation and supporting longevity, peptides have a wide range of applications
The same teaspoon in a large jug creates barely sweet water
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Patience and consistency matter more than dose tweaking or adding more compounds
Heavy metals accumulate in biological tissue and produce confounding effects in long-term studies
5-Amino-1MQ is a substrate-mimetic inhibitor that occupies the nicotinamide binding site, with a reported IC of 1.2 0.1 M (Neelakantan et al., J Med Chem, 2017)